Dr. Bobbi Pritt previews new infectious diseases guide in “CAP TODAY”
Bobbi Pritt, M.D.
In the “Put it on the Board” section of the August “CAP TODAY,” Bobbi Pritt, M.D., was interviewed about a new guide recently published by the Infectious Diseases Society of America and the American Society for Microbiology, which is intended to help physicians use laboratory tests appropriately in diagnosing infectious diseases. According to the article, the guide was published on July 11 in “Clinical Infectious Diseases” and its ”recommendations provide guidance on which lab tests are valuable and should be used in specific contexts, which add little or no value, and how to collect and manage specimens.”
Bobbi Pritt, MD, MSc, D(TMH), a coauthor of the guide and a member of the CAP Microbiology Resource Committee, says some of the most important aspects of microbiology testing are in the guide’s introduction—for example, “that the microbiologist is an essential part of the patient care team,” she says, “who must be allowed to make decisions regarding workup of the microbiology specimen.” Ultimately, some specimens will not be suitable for testing and the lab must reject them.
“Clinicians can avoid specimen rejection by discussing the case with the microbiologist prior to sample collection, and by adhering to general rules for optimal specimen selection such as submitting tissues, fluids, and aspirate rather than swabs whenever possible, obtaining specimens prior to administration of antibiotics, and taking steps to avoid contaminating a specimen with normal flora,” says Dr. Pritt, director of clinical parasitology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minn.